SciBase Holding AB (publ) (STO:SCIB)

Market Cap	134.80M
Revenue (ttm)	32.50M
Net Income (ttm)	-77.77M
Shares Out	366.30M
EPS (ttm)	-0.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	305,932
Average Volume	415,556
Open	0.3800
Previous Close	0.3650
Day's Range	0.3650 - 0.3950
52-Week Range	0.3000 - 0.5980
Beta	1.18
RSI	47.26
Earnings Date	Aug 19, 2025

About SciBase Holding AB

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Ne...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 32
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SCIB

Financial Performance

In 2024, SciBase Holding AB's revenue was 29.71 million, an increase of 27.79% compared to the previous year's 23.25 million. Losses were -61.13 million, 9.97% more than in 2023.